Dysbiosis of the Fecal Microbiota in the TNBS-induced Crohn's Disease Mouse Model
Overview
Biotechnology
Microbiology
Authors
Affiliations
Crohn's disease (CD) is characterized by chronic transmural inflammation. The symptom of the mice model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) is closed to human under CD condition, so this kind of animal is widely used in the related researches. Although the dysbiosis of the fecal microbiota has been proved to play an important role in the patients with CD, the composition of the gastrointestinal microbiota in the mouse model under disease condition is still unclear. In the current study, male 7-week BALB/c mice were anesthetized and intrarectal administrated by ethanol (ET group), TNBS in ethanol (TN group), and phosphate buffered saline (PBS) (CK group) as control. The symptoms of individuals under the CD condition were observed, and the changes of the bacterial taxonomic structure and functional composition were revealed by next-generation sequencing (NGS) 16S sequencing. The BALB/c mice in TN group demonstrated CD-like symptoms and the damages in the intestinal tract. The NGS 16S results exhibited that the diversity and microbial composition under CD condition are significantly different with those in ET group. The KEGG Orthology (KO) profile were generated from PICRUSt, and function modules such as methanogenesis (M00347) and microcin C transport system (M00349) were found enriched in the individuals in the TN group. This study proved that mouse model induced by TNBS could develop the similar symptom to CD patient, and we firstly showed the significant intestinal microbe changes on both taxonomic structure and functional composition in this mouse model.
Probiotic Microorganisms in Inflammatory Bowel Diseases: Live Biotherapeutics as Food.
Santos E, Magalhaes-Guedes K, Borges F, Ferreira D, da Silva D, Conceicao P Foods. 2025; 13(24.
PMID: 39767038 PMC: 11675991. DOI: 10.3390/foods13244097.
Gut Microbiota Profiling as a Promising Tool to Detect Equine Inflammatory Bowel Disease (IBD).
Savilammi T, Alakangas R, Hayrynen T, Uusi-Heikkila S Animals (Basel). 2024; 14(16).
PMID: 39199930 PMC: 11350833. DOI: 10.3390/ani14162396.
Yang F, Ni B, Liu Q, He F, Li L, Zhong X Stem Cell Res Ther. 2022; 13(1):475.
PMID: 36104756 PMC: 9476645. DOI: 10.1186/s13287-022-03118-1.
A Wipe-Based Stool Collection and Preservation Kit for Microbiome Community Profiling.
Hua H, Meydan C, Afshin E, Lili L, DAdamo C, Rickard N Front Immunol. 2022; 13:889702.
PMID: 35711426 PMC: 9196042. DOI: 10.3389/fimmu.2022.889702.
Modesto R, Estarreja J, Silva I, Rocha J, Pinto R, Mateus V J Clin Med. 2022; 11(10).
PMID: 35628865 PMC: 9146029. DOI: 10.3390/jcm11102739.